Serial #79430099
LIVE

Serial Number

79430099

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

Apr 25, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79430099 Trademark

Serial Number: 79430099 • Registration: 8131912

Serial #79430099 is a trademark filed by Novartis AG on April 25, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

April 25, 2025

Registration Date

February 10, 2026

Published for Opposition

December 23, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 10, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 10, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 10, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 23, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 17, 2025 NONP
REFUSAL PROCESSED BY IB
Dec 5, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 29, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 29, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 29, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 26, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 26, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2025 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Sep 29, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 17, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 12, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 14, 2025 REPR